New Mitral Frontier 🚪🫀🚶‍♂️ TMVR Opens a Third Pathway episode artwork

EPISODE · Nov 3, 2025 · 5 MIN

New Mitral Frontier 🚪🫀🚶‍♂️ TMVR Opens a Third Pathway

from Dr RR Baliga's "Got Knowledge Doc" Podkast · host MasterMedFacts LLC

A new era for complex mitral regurgitation. The ENCIRCLE pivotal trial in The Lancet reports that fully percutaneous, transfemoral, transseptal TMVR (SAPIEN M3) achieved durable MR reduction (≈96% ≤1+ at 1 year), low early mortality, and meaningful improvement in symptoms and quality of life for patients unsuitable for surgery or TEER.   A third pathway for mitral disease is emerging—one built on precision access, valve-in-valve durability planning, and advancing patient selection.   Innovation meeting clinical need. 🚀🫀📈

Episode metadata supplied by the publisher feed · Published Nov 3, 2025

NOW PLAYING

New Mitral Frontier 🚪🫀🚶‍♂️ TMVR Opens a Third Pathway

0:00 5:14

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Dr RR Baliga's "Got Knowledge Doc" Podkast?

This episode is 5 minutes long.

When was this Dr RR Baliga's "Got Knowledge Doc" Podkast episode published?

This episode was published on November 3, 2025.

What is this episode about?

A new era for complex mitral regurgitation. The ENCIRCLE pivotal trial in The Lancet reports that fully percutaneous, transfemoral, transseptal TMVR (SAPIEN M3) achieved durable MR reduction (≈96% ≤1+ at 1 year), low early mortality, and meaningful...

Can I download this Dr RR Baliga's "Got Knowledge Doc" Podkast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!